Wm Technology
OTC: MAPS
$0.36 ▲ +0.00  (+0.00%)
At close: Jul 23, 2026 · 4:00 PM UTC
Financial Ratios
Market Cap39.81 Mn
P/E16.16
P/S0.23
Div. Yield0.03
Revenue Growth (1y) (Qtr)-2.36
Add ratio to table…

About

WM Technology, Inc. operates a leading online cannabis marketplace and provides a suite of eCommerce and compliance software solutions for cannabis businesses in the United States. The company’s platform includes the Weedmaps consumer marketplace for product discovery and the Weedmaps for Business software-as-a-service offering that helps retailers and brands manage operations and comply with state regulations. WM Technology, Inc. generates revenue primarily through…

Read more ↓
Sector: Technology Industry: Software - Application CIK: 0001779474

Investment Thesis

▲ Bull case
  • Weedmaps operates in a structurally evolving cannabis industry where consolidation is creating a bifurcated market dominated by large, financially stable MSOs and legacy California operators, both of which represent high-value, long-term clients for the platform. Despite short-term revenue pressure from pricing compression and illicit competition, the company’s strategic focus on enhancing product discovery and marketplace experience—particularly through product-first shopping journeys—positions it to capture increased engagement and spending from these consolidating operators as they seek efficient customer acquisition channels in a constrained advertising environment. The platform’s value proposition is amplified in markets where regulatory capture limits organic growth, making Weedmaps a critical tool for visibility and market share, a dynamic management is actively leveraging in New York, Minnesota, and Texas. Early success in New York, where average paying clients nearly doubled year-over-year, demonstrates the scalability of their go-to-market model in new entrants states, suggesting replicable potential in other underpenetrated markets with similar regulatory frameworks. Furthermore, the company’s strong liquidity position—ending 2025 with $62 million in cash, up nearly 20% year-over-year—provides a significant buffer to fund these strategic investments without relying on external financing, even as it forgoes formal EBITDA guidance due to investment timing variability. This financial discipline, combined with targeted reductions in sales and marketing ($2 million decrease) and product development ($8 million decline), reflects a deliberate reallocation of capital toward high-impact, long-term growth initiatives rather than indiscriminate cost cutting. The absence of EBITDA guidance should not be interpreted as weakness but as confidence in the company’s ability to self-fund innovation through operating cash flow, which remains robust despite revenue headwinds. Most critically, while Schedule III rescheduling will not federally legalize cannabis or immediately enable new revenue streams, its implementation will reduce the stigma and operational uncertainty surrounding ancillary cannabis technology firms like Weedmaps, potentially unlocking future monetization pathways—such as enhanced data analytics, compliance tools, or B2B SaaS offerings—that are currently constrained by the company’s exchange listing and federal illegality status. Management’s restrained commentary on Schedule III may be understating its role as a necessary precursor to broader institutional acceptance and future strategic flexibility, which could meaningfully expand the company’s addressable market beyond its current lead-generation model.
▼ Bear case
  • Weedmaps faces persistent and structural headwinds in its core mature markets—California, Michigan, and Oklahoma—where severe pricing pressure, illicit market competition, and elevated excise taxes are directly eroding client marketing budgets and reducing average revenue per paying client, which remains stagnant at approximately $2,800 for both the quarter and the year despite efforts to upsell or increase engagement. This dynamic is not cyclical but structural, driven by long-term industry trends including operator consolidation, which Francis explicitly acknowledged reduces platform competitiveness by narrowing the base of active advertisers—a critical flaw for a marketplace model that thrives on density and competition among vendors. The company’s reliance on mature markets for revenue stability is increasingly untenable, as full-year revenue declined 5% to $175 million and average paying clients in key states continue to contract, with growth in New York and other emerging markets insufficient to offset losses, as evidenced by sequential client count declines of approximately 2% in Q4 FY25. Management’s admission that first-quarter revenue is expected to decline sequentially by mid- to high single digits confirms near-term momentum remains negative, and the decision to withhold adjusted EBITDA guidance for 2026 underscores uncertainty around investment timing and returns, signaling a lack of near-term visibility into profitability trends despite claims of financial flexibility. While operating expenses rose only 2% year-over-year to $174 million, this modest increase masks significant underlying strain: a $6 million rise in general and administrative expenses—driven by a $2.3 million noncash loss contingency tied to a server provider and a $2.8 million legal settlement—offset reductions in sales and marketing and product development, suggesting that cost discipline is being undermined by avoidable operational and legal liabilities. Furthermore, the $7.8 million goodwill impairment charge in Q4 FY25 reflects a sobering reassessment of the value of past acquisitions, indicating that historical investments may not be generating the expected returns, a red flag for long-term value creation. The company’s strategic pivot toward product enhancements and marketplace experience, while logically sound, remains unproven at scale and risks becoming a distraction if core monetization channels continue to deteriorate. Most critically, Francis’s explicit statement that Schedule III rescheduling “will not make cannabis federally legal nor will it immediately allow Weedmaps to enter new business lines or launch new revenue strategies” eliminates a major near-term catalyst that investors may be pricing in, leaving the company dependent on incremental gains in regulated markets where client acquisition costs are high and monetization per user remains low. Without a clear path to federally compliant transactions, e-commerce functionality, or access to banking services—all blocked by its exchange listing and federal illegality—Weedmaps remains confined to a lead-generation role with limited pricing power, making it vulnerable to displacement by operators building their own direct-to-consumer channels or by platforms better positioned to navigate regulatory complexity.

Product and Service Breakdown of Revenue (2025)

Segments Breakdown of Revenue (2025)

Peer Comparison

Companies in the Software - Application
S.No. Ticker Company Market CapP/EP/STotal Debt (Qtr)
1 SAP Sap Se 208.91 Bn20.224.867.05 Bn
2 YMM Full Truck Alliance Co. Ltd. 188.77 Bn322.09-0.00 Bn
3 SHOP Shopify Inc. 145.98 Bn109.5911.80-
4 UBER Uber Technologies, Inc 141.48 Bn16.322.6410.51 Bn
5 CRM Salesforce, Inc. 128.51 Bn16.953.0039.28 Bn
6 NOW ServiceNow, Inc. 98.38 Bn54.177.057.52 Bn
7 ADP Automatic Data Processing Inc 97.56 Bn22.454.523.98 Bn
8 SNOW Snowflake Inc. 91.55 Bn-76.6318.19-